Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Stock indices provide benchmarks and a lens into market trends. This overview explains their purpose and how investors leverage them.
16,698 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
June delivered a sharp tilt in energy markets as crude prices slid. This article breaks down why prices swooned june....
SpaceX announces a year-long insider lockup with a 15-date unlock schedule to follow. The move tests liquidity expect...
Broadcom surges after expanding its custom-chip partnership with Apple through 2031, boosting peers like AMD and Inte...
TeraWulf signs a 20-year deal with Anthropic for a 401 MW data center campus in Kentucky, locking in about $19 billio...
Occidental Petroleum climbs on an Evercore upgrade and a stronger oil backdrop, outpacing ExxonMobil and Chevron as t...
SK hynix prepares to begin trading on Nasdaq with ADRs priced at $149, in a move that broadens access to AI memory ex...
Small, consistent savings can compound into meaningful retirement wealth. This article breaks down the math behind sa...
Retirees chasing large payouts face a hidden danger: high yields often come from falling stock prices rather than str...
Tech markets are split: cybersecurity chip stocks soaring as AI chips gain traction, even as software stocks wobble. ...
Arm Holdings faces a cooling pullback after a strong rally, offering a potential entry point for long-term investors....